Hiccups on GLP-1 medicines

What the official product information says

A US label lists a reaction in its main table only if enough people reported it, usually at least 2% of those on the medicine and more than on placebo. Rarer events may be mentioned in the text, or not at all. That is why the absence of hiccups from most labels says little about whether they ever happen; it says they were not common enough, or not recorded separately enough, to be counted.

In the Wegovy® label, the paragraph on gastrointestinal reactions in adults treated for weight reduction names hiccups next to indigestion, burping, reflux and gastritis, and adds that these reactions were reported most often during dose escalation ^[1]. The table below shows where hiccups are and are not mentioned, with the nearest reactions that do have numbers.

What research adds

No clinical trial we found measured hiccups as an outcome. The most specific evidence comes from pharmacovigilance, the study of reports that patients and clinicians send to regulators. One analysis of the FDA Adverse Event Reporting System from 2018 to 2022 looked at 5,442 semaglutide cases involving the digestive system. Hiccups appeared in 47 of them and were reported more often with semaglutide than with other medicines in the database, earning a moderate clinical-priority rating ^[11].

This kind of study has firm limits. It counts reports, not patients, so it cannot give a rate. People are more likely to report a side effect they have read about, and the analysis cannot rule out other causes. The authors also noted that digestive reports clustered early in treatment and became less frequent over time, which fits the label’s statement about dose escalation ^[1][11].

Reflux, one of the recognised triggers for longer-lasting hiccups, has been studied more directly. In a UK cohort of adults with type 2 diabetes, people starting a GLP-1 medicine had a higher three-year risk of a new reflux diagnosis than those starting an SGLT-2 inhibitor, although the absolute difference was under one person in a hundred ^[12]. That study did not look at hiccups themselves.

Why a GLP-1 medicine might set off hiccups

It helps to keep apart what is documented, what is plausible and what is simply general knowledge about hiccups.

• Documented: these medicines slow how quickly the stomach empties, an effect the tirzepatide label describes as strongest after the first dose and fading with time ^[4]. Burping, reflux and indigestion are all more common than on placebo ^[1][4][7].
• Plausible but unmeasured: a hiccup is a sudden contraction of the diaphragm followed by a snap closure of the vocal cords ^[13]. It starts when the nerves that run that reflex, including the vagus and phrenic nerves, are irritated ^[14]. A fuller stomach that empties slowly, or acid moving upwards, could be the irritant. No study has tested this chain for GLP-1 medicines.
• General: short bouts follow eating too much or too fast, fizzy drinks, swallowed air, alcohol, smoking and very hot, cold or spicy food ^[14]. Often there is no clear trigger ^[13].

Other causes worth keeping in mind

Hiccups that last for days have a long list of possible causes that have nothing to do with weight or diabetes medicines. Cleveland Clinic names reflux and gastritis, conditions affecting the brain such as stroke, lung problems including pneumonia or a clot in the lung, some infections, kidney failure with a build-up of waste in the blood, low calcium, tumours along the chest or gullet, and recent surgery or anaesthesia ^[14].

Some medicines are known culprits too, including steroids such as dexamethasone, some chemotherapy drugs, certain antibiotics and low doses of benzodiazepines ^[14]. If you take any of these alongside a GLP-1 medicine, mention both when you describe the hiccups.

What tends to help

There is no reliable cure for an ordinary bout. MedlinePlus and Cleveland Clinic list the familiar options: holding your breath briefly, sipping or gargling cold water, breathing into a paper bag, or swallowing a spoonful of sugar ^[13][14]. They may work by stimulating the vagus nerve or raising carbon dioxide in the lungs, but the evidence is anecdotal ^[14].

For prevention, Cleveland Clinic suggests eating and drinking more slowly, taking smaller portions at a time, cutting back on fizzy and alcoholic drinks, and avoiding very hot or cold food ^[14]. These overlap with the eating habits often discussed for nausea and fullness on GLP-1 medicines, so one change may help with more than one symptom.

Medicines for persistent hiccups exist, but choosing one is a prescriber’s decision based on the cause ^[14]. Do not stop or change your GLP-1 medicine on your own because of hiccups.

Writing it down

Cleveland Clinic suggests keeping a short journal when hiccups keep returning, so you can spot what came right before them ^[14]. With a weekly injection, the useful details are the day and time of the dose, whether the dose recently went up, what you ate and drank before the bout, how long it lasted and whether burping or heartburn came with it.

Ozempic®, Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound® and Trulicity® are registered trademarks and Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.